The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
“Management Migration” in United States patients diagnosed with localized prostate cancer from 2010-2015.
 
Santino Butler
No Relationships to Disclose
 
Idalid Ivy Franco
No Relationships to Disclose
 
Amandeep R Mahal
No Relationships to Disclose
 
Nina Niu Sanford
No Relationships to Disclose
 
Quoc-Dien Trinh
Honoraria - Astellas Pharma; Bayer
 
Timothy Rebbeck
No Relationships to Disclose
 
Paul L. Nguyen
Stock and Other Ownership Interests - Augmenix; Volatilyx (I)
Consulting or Advisory Role - Astellas Pharma; Augmenix; Augmenix; Bayer; Biogen (I); Blue Earth Diagnostics; Coda; Dendreon; Ferring; GenomeDx; GigaGen (I); Infinity Pharmaceuticals (I); Medivation; Nanobiotix
Research Funding - Astellas Pharma; Janssen; Nanobiotix; Wako Diagnostics (I)
Patents, Royalties, Other Intellectual Property - Wife has a patent on volatile diagnostics of infections (I)
Travel, Accommodations, Expenses - Ferring
 
Anthony Victor D'Amico
No Relationships to Disclose
 
Brandon Arvin Virgil Mahal
No Relationships to Disclose